Search Medical Condition
Please enter condition
Please choose location from dropdown

Tangshan, China Clinical Trials

A listing of Tangshan, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (9) clinical trials

BioheartRapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study

This study is a prospective, multicentred randomized controlled trial, planning to enroll 430 subjects and randomize 1:1 to study group and control group. All subjects will accepte clinical evaluation at 1 month, 6 month, 9 month and 1, 2, 3, 4, 5 year post procedure. All subjects will accepte angiographic ...

Phase N/A

0.0 miles

Learn More »

High-intensity Versus Conventional-intensity Noninvasive Positive Pressure Ventilation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: the HAPPEN Study (HAPPEN)

The main purpose of the present study is to verify whether, as compared with conventional-intensity noninvasive positive pressure ventilation, high-intensity noninvasive positive pressure ventilation may more effective in correcting hypercapnia, hence reducing the need for intubation and improving survival in patients with acute exacerbation of chronic obstructive pulmonary disease.

Phase N/A

0.0 miles

Learn More »

China Cognition and Aging Study

This study involved participants including amnestic mild cognitive impairment (aMCI), sporadic Alzheimer's disease (SAD), familial Alzheimer's disease (FAD), Vascular cognitive impairment (VCI), and APOE gene cohort (cognitive normal subjects). Research contents are as follow Neuropsychological characteristics of Chinese aMCI, SAD, VCI: analyze the cognitive function, daily living ability and mental ...

Phase N/A

0.0 miles

Learn More »

The Chinese Familial Alzheimer's Network

Set up a multi-center, national-wide FAD research network and electronic database platform in China, including ADAD cohort of the known mutations PSEN1, PSEN2 and APP (mutation carriers and noncarriers; presymptomatic and symptomatic) and unknown mutation cohort. Clarify the genetic characteristic of familial Alzheimer's disease, and find risk and protective genes ...

Phase N/A

0.0 miles

Learn More »

Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin

This study will be conducted in approximately 36 sites in Asian countries. Approximately 1004 subjects will be screened and 342 randomized. Prior to the screening, subjects of Stratum A should have a stable dose of metformin (1500 mg/day or a maximal tolerated dose) for at least 8 weeks. And subjects ...

Phase

0.0 miles

Learn More »

Intracranial Thrombosis Aspiration Catheter for Recanalization in Acute Ischemic Stroke Therapy (RECOVER)

This study is a prospective, multi-center, open-label, end-point blinded, parallel positive controlled, non-inferiority clinical trial. Patients with acute ischemic stroke (AIS) who meet inclusion criteria would be enrolled in this study. Led by Beijing Tiantan Hospital affiliated to Capital Medical University, this study is planned to be carried out in ...

Phase N/A

0.0 miles

Learn More »

Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign

The Tranexamic Acid for Acute ICH Growth prEdicted by Spot Sign (TRAIGE) is a is a multicentre, randomized, placebo-controlled, double-blind, prospective, investigator-led, clinical trial of tranexamic acid within 6 hours of intracerebral hemorrhage in patients with contrast extravasation on CTA, 'the spot sign'. ICH patients within 6 hours of symptom ...

Phase

0.06 miles

Learn More »

Protective Effects of Saxagliptin (And Vitamin D3) on Cell Function in Adult-onset Latent Autoimmune Diabetes

LADA is actually a form of type 1 diabetes, which is caused by autoimmune damage of islet cells and triggered by environmental factors based on genetic susceptibility. LADA shows some characteristics of type 2 diabetes at its onset, which develops slowly and latent, and easily be misdiagnosed as type 2 ...

Phase

0.06 miles

Learn More »

Stroke Imaging Package Study of Intracranial Atherosclerosis ( SIPS-ICAS )

First-ever stroke patients attributed to intracranial artery stenosis (> 50%) within 7 days after onset will be prospectively enrolled in our study and undergo new imaging technique package assessment at baseline. The imaging technique package includes conventional cranial MRI T1,T2,T2 FLAIR,DWI, and ADC), cranial magnetic resonance angiography (MRA), intracranial vessel ...

Phase N/A

0.06 miles

Learn More »